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Venous reflux repair with cryopreserved vein valves
Peter Negle´n, MD, PhD, and Seshadri Raju, MD, Jackson, Miss
Purpose: The purpose of this study was to evaluate the immediate and short-term outcome of inserted cryopreserved vein
valve allografts and the clinical outcome of treated limbs.
Method: Twenty-seven cryovalves were inserted in 25 postthrombotic limbs because of active leg ulcer (20 limbs) or severe
disabling leg pain (five limbs) as a procedure of last resort. Previous venous surgery had been performed in 80% of the
limbs. Main stem superficial reflux and iliac venous outflow obstruction were controlled before cryovalve insertion. The
most common insertion site was the superficial femoral or popliteal vein. Patients were followed up with clinical
examination and with intermittent duplex Doppler scanning or ascending venography to assess patency and competency
of the valve station.
Results: After thawing, but before insertion, 74% of the cryovalves were incompetent and needed repair with transcom-
missural valvuloplasty. After insertion, mortality was zero. Morbidity was 48%, mainly because of seroma formation and
deep wound infection. One cryovalve was explanted because of acute rejection. Six cryovalves occluded early (<6 weeks),
and five occluded late. Cumulative rates of patent cryovalves and both patent and competent cryovalves at 24-month
follow-up were 41% and 27%, respectively. Cumulative ulcer recurrence-free rate at 36 months was 50%. Pain relief was
poor, and degree of swelling remained the same.
Conclusion: Compared with autologous vein transfer, cryovalve insertion is associated with high morbidity, high
occlusion rate, poor cumulative midterm rate of patent graft with competent valve, and poor clinical results. The
procedure should not be used as a primary technique for valve reconstruction, and it is questionable whether it is useful
even in patients in whom autologous reconstruction techniques have been exhausted. The basis of the high failure rate is
unclear; it may be immunologic or due to loss of endothelial cover after implantation. If cryovalves are to be a viable valve
repair alternative, improved cryopreservation technique, immunologic modifications, or better matching must be
achieved. (J Vasc Surg 2003;37:552-7.)
Internal and transcommissural valvuloplasty proce-
dures provide the best long-term patency with competent
valves.1-3 This type of repair cannot be accomplished, how-
ever, when the valve leaflets have been destroyed beyond
repair, typically in patients with postthrombotic disease of
the deep veins. In such cases an autologous axillary vein
transfer must be performed to control deep venous reflux.
Although this is the best available autologous vein trans-
plant procedure, it is by no means an optimal alternative.
Even bilateral exploration of the armpit reveals no usable
valve station in 14% of patients. Although an axillary vein is
present, it is found incompetent in 44% of upper limbs.
Most (92%) can be repaired with transcommissural valvu-
loplasty in situ. Still, approximately 15% of transferred
valves remain mildly leaky after insertion.4,5 Therefore the
ultimate goal in venous surgery is to find an off-the-shelf
valve to replace the defunct valve in the deep venous
system. The commercial availability of cryopreserved ve-
nous valve allografts (or cryovalves) has held the promise of
fulfilling that goal. Initial clinical experience suggested that
the cryovalve is a safe biovalve substitute with reasonable
patency and competency in the short term and therefore
can be inserted as a last resort salvage procedure in selected
cases.6 In clinical practice, we evaluated use of cryopre-
served venous valve segments to control postthrombotic
deep venous reflux in limbs with severe chronic venous
insufficiency. The study was performed prospectively and
on an intent-to-treat basis. Immediate and midterm clinical
outcome of the treated limb and of the inserted cryovalve
venous segments is described.
MATERIAL AND METHODS
Between September 1997 and December 2001 we
studied 25 patients with severe postthrombotic disease (left
limb 16, right limb 9; men 17, women 8; median
age, 44 years, range, 32-81 years). The primary indication
for valve surgery was active venous stasis ulcer in 20 pa-
tients, and severe postthrombotic pain and lipodermato-
sclerosis or stasis dermatitis in five. The median duration of
symptoms was 7 years (range, 2-20 years). Thrombophilia
testing yielded positive results in 14 of 23 tested patients
(61%), including protein S or protein C deficiency in 6,
anticardiolipin immunoglobulin M and immunoglobulin
G positivity in 5, antithrombin III deficiency in 2, and
presence of Leyden factor in 1. Cryopreserved venous valve
allografts were inserted as a salvage procedure after other
methods of valve reconstruction were either unavailable or
had been exhausted. Last-resort treatment was indicated
because 20 of 25 limbs (80%) had undergone previous
venous procedures in addition to conservative treatment
with compression and ulcer care (Table I). Main stem
superficial reflux and iliac venous outflow obstruction, if
present, were controlled before surgery, leaving the axial
deep reflux as determinant.
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Air plethysmography (APG-1000; ACI Medical Inc,
Sun Valley, Calif), duplex Doppler scanning with standard-
ized compression, and ascending and descending venogra-
phy were performed, and arm-foot pressure differential,
dorsal foot venous hyperemia pressure, and ambulatory
dorsal foot venous pressure measurements were obtained in
all patients before surgery, as described.7-9 Results of pre-
operative venous function studies are given in Table II. All
limbs had marked axial deep venous reflux, but in six limbs
a combination of venous outflow obstruction and reflux
was observed (grade 2 or higher, Raju classification9).
Results of the Raju pressure-based test were positive, prob-
ably because of infrainguinal obstruction, because iliac ve-
nous outflow had been ensured with venous stenting when
necessary (Table I). CEAP classification, according to Re-
porting Standards of the International Society for Cardio-
vascular Surgery and the Society for Vascular Surgery,10
was C6sEsAdPr in 14 limbs, C6EsAdPr/o, in 6, and
C4sEsAdPr in 5.
A valve site amenable to repair was chosen according to
findings at ascending and descending venography and erect
duplex Doppler scanning. All sites were explored with the
intent to perform valvuloplasty or axillary vein transfer to
control deep reflux. When autologous valve reconstruction
was not possible, a decision was made to insert a cryopre-
served valve. In 19 of the 25 limbs cryopreserved valve
insertion was performed 1 to 7 days later through the same
incision; in 6 limbs a cryovalve was immediately available
and inserted at the same procedure.
Twenty-seven cryovalves were inserted in 25 limbs.
Twenty-three limbs received single-segment insertions, in
the common femoral vein in 1, superficial femoral vein in
14, profunda vein in 3 (all limbs had axial transformation of
the profunda vein with complete obstruction of the femoral
vein), and popliteal vein in 5. Two limbs received dual
cryovalve insertions, one each in the superficial femoral and
profunda femoris veins.
Details of the surgical procedure have been described6;
however, some aspects of the procedure were different in
our study. The cryopreserved venous valve allografts ie,
cadaveric superficial femoral veins, were shipped at70° C
from Cryolife (Kennesaw, Ga). ABO blood group and
Rhesus factor (Rh) compatibility between donor tissue and
recipient was ensured, although Rh compatibility is not
required by the manufacturer. Rh compatibility may be an
issue in fertile women and in patients who may require
additional future cryovalve insertions. The cryovalves were
shipped with appropriate certification regarding hepatitis
and human immunodeficiency virus negativity in donor
sera. The allograft was thawed according to a four-step
protocol, meticulously followed, immediately before use.
The texture and feel of the thawed biovalve are essentially
no different from that of fresh autologous tissue, except for
some increased variable thickness of the thawed vein.
Sizing of the cryopreserved allograft was made during
surgery. An appropriate allograft width was selected to
ensure an optimal diameter match to the native vein. The
length of the graft varied depending on the number of valve
stations used. Sufficient length of donor vein was used to
prevent interference with the valve station at insertion.
Comparable length of recipient vein to donor vein was
removed to allow optimal fit. End-to-end anastomosis was
performed with 6-0 nonabsorbable suture. The manufac-
turer certifies that at least one valve in each shipped seg-
ment is competent. However, 20 of 27 cryovalves (74%)
were incompetent at negative or positive strip testing after
being thawed. We were able to repair all refluxive valves
with the transcommissural technique3 and render them
competent before insertion. In addition, 30% of vein seg-
ments contained two or more valve stations. An attempt
was made in such cases to ensure that all valves in the
inserted segment were competent and functional to (pre-
sumably) further improve reflux control. No distal arterio-
venous fistula was used in any limb. Five thousand units of
heparin was administered intravenously during surgery,
followed by immediate postoperative anticoagulation with
orally administered coumadin and daily dalteparin injec-
tions subcutaneously until therapeutic international nor-
malized ratio levels were attained. All patients were encour-
aged to use CircAid legging (CircAid Medical Products,
Inc, San Diego, Calif) postoperatively until ulcer healing.
Informed consent was obtained from patients before the
operation. The study was approved by the Institutional
Review Board of River Oaks Hospital, Jackson, Miss.
Outcome assessment. The repaired vein site was
observed regularly postoperatively with duplex Doppler
scanning or ascending venography to record patency and
competency of the inserted cryopreserved valve segment.
Incompetence of the vein segment was defined as duration
of reflux exceeding 0.5 seconds. The limb operated on was
also observed clinically. The study end point of legs with
stasis ulceration was healing, ie, complete epithelialization.
Any breakdown of the ulcer after healing was considered a
recurrence. The degree of pain was evaluated with a visual
analog scale of 0 to 10, with 10 indicating the most severe
pain.10 Swelling was assessed as grade 0, absent; grade 1,
pitting, not obvious; grade 2, visible ankle edema; or grade
Table I. Previous surgery in 20 of 25 limbs with
cryopreserved valve insertion
Transcommissural valvuloplasty 3
Transcommissural valvuloplasty plus long saphenous vein
stripping
1
Axillary vein transfer 1
Axillary vein transfer plus iliac vein stenting 1
Axillary vein transfer plus transcommissural valvuloplasty 1
Iliac vein stenting 4
Iliac vein stenting plus stab avulsion plus Palma bypass
procedure (failed)
1
Iliac vein stenting plus long saphenous vein stripping plus
stab avulsions
1
Long saphenous vein stripping plus stab avulsions 3
Long saphenous vein stripping plus stab avulsions plus
modified Linton procedure
1
Long and short saphenous vein stripping plus stab avulsions 1
Short saphenous vein stripping plus stab avulsions 1
Popliteal vein release 1
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3, massive, encompassing the entire leg. Venous function
studies were repeated at follow-up.
Statistical analysis was performed with GraphPad Prism
version 3.00 for Windows (GraphPad Software, San Diego,
Calif). Wilcoxon rank paired nonparametric tests were used
in the appropriate setting to evaluate statistical significance.
P .05 was considered significant. Cumulative ulcer recur-
rence-free, valve competency, and patency rates were cal-
culated by using survival analysis with the Kaplan-Meier
method.
RESULTS
Mortality was zero. Wound complications occurred in
12 of 25 limbs (48%). Two limbs with superficial wound
infection and one limb with cellulitis required only antibi-
otic treatment. In addition, 4 deep wound infections, 3
large seromas, and 1 wound hematoma required surgical
drainage. Explantation of the cryopreserved vein segment
was necessary in one patient 6 days after insertion, because
of acute rejection clinically, later verified by immune reac-
tion at histopathologic analysis. The removed cryovalve
segment was replaced with another. Because of hematoma
formation, this cryovalve was explored 2 days later. The
graft was thick-walled, stiff, and incompetent, but was left
in place for outflow because of a remaining lumen. The
patient was lost to follow-up.
Patency and competence were detected with duplex
ultrasound scanning or ascending venography in 21 of 25
limbs (23 of 27 implantation sites) at a median follow-up of
11 months (range, 1-41 months) after surgery. Forty-one
percent of the implants occluded (11 of 27 sites). Six
occlusions occurred early postoperatively (6 weeks) in
five patients despite adequate anticoagulation therapy. In
one patient anticoagulation appears to have been inade-
quate after warfarin sodium treatment was being managed
by the local physician. Five vein segments in four patients
occluded later (3 to 17 months), apparently related to
independent discontinuation of warfarin sodium by three
patients and poor regulation of anticoagulation in one.
Three of these cryovalves appeared competent on preocclu-
sion ultrasound scans. Catheter-directed thrombolysis was
attempted in three early occlusions but was unsuccessful.
Typically, early thrombosis produced not only marked local
inflammatory reaction at the insertion site but also systemic
symptoms with fever and malaise. At last follow-up 12 valve
sites were patent, with eight competent valves, three in-
competent valves (duration of reflux, 2.5-3.7 s), and one
leaky valve (duration of reflux, 0.8 s). At 24-month follow-
up, cumulative rate for patent cryovalves was 41% and for
both patent and competent cryovalves, 27% (Figs 1 and 2).
The overall rate for patent and competent cryovalves before
late occlusion in valves with and without transcommissural
repair before insertion was 56% and 42%, respectively (dif-
ference not significant).
Three limbs (2 of 20 with leg ulcer and 1 of 5 with
painful limb) were lost to clinical follow-up (median, 20
months; range, 2-49 months). The cumulative ulcer recur-
rence-free rate for 18 limbs is shown in Figure 3. At
36-month follow-up, 50% of limbs were ulcer-free. Early
occlusion of the cryovalve in two limbs with ulcer resulted
in healing in one and no improvement in the other. None
of the patients whose main symptom was leg pain, without
leg ulcer, had any improvement, explained by early occlu-
sion of the cryovalve in 3 of 4 such limbs. There was no
significant difference in median pain score for the entire
group of 22 symptomatic limbs with preintervention values
of 3 (range, 0-9) to 1 (range, 0-8) (difference not signifi-
cant) after intervention, and the degree of swelling re-
mained the same (median, 1; range, 0-3).
There appeared to be some relationship between ulcer
healing and long-term patency and competency of the
inserted cryovalve. In most limbs with ulceration (14 of 15
[93%]) there was healing of the ulcer when the cryovalve
remained patent and competent 6 weeks after insertion.
One patient had a massive circumferential leg ulcer, which
decreased in size but never healed completely. The stasis
ulcer remained healed during the observation period in all
limbs with a competent and patent cryovalve (6 limbs). The
ulcer recurred, however, in all limbs, and later reflux devel-
oped in five limbs in which the valve had been competent,
but remained healed in three patients with late complete
occlusion without reflux.
Hemodynamic tests, including ambulatory venous
pressure drop, venous filling time, venous filling index at
90%, and ejection fraction, were repeated in 16 limbs after
surgery (Table II). No significant change in these parame-
ters was observed in the total group of limbs or when
fractionated into groups of patent limbs, occluded limbs,
and both patent and competent limbs. Thus results of these
functional tests demonstrated no hemodynamic improve-
ment.
Table II. Preoperative and postoperative hemodyamic results in 25 limbs
Preoperative value
(n  25)
Postoperative value
(n  16) P
Ambulatory venous pressure drop (%) 43 (15-87) 52 (40-80) NS
Venous filling time (s) 6 (2-33) 8 (2-64) NS
Venous filling index at 90% (mL/s) 4.0 (0.6-14.0) 3.8 (0.4-6.2) NS
Ejection fraction (%) 51 (23-100) 45 (19-86) NS
Data represent median, with range in parentheses.
NS, no significance.
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DISCUSSION
Cryovalve cumulative patency and competency rates of
78% and 67%, respectively, at 6 months, described in a
phase I study,6 were similar to our study, but were not
maintained with longer follow-up. At 2 years, patency and
competency rates had progressively deteriorated to 41%
and 27%, respectively. Autologous axillary vein transfers in
a similar group of patients fared considerably better, with a
lower occlusion rate (0%-18%) and higher competency rate
(40% or better) than that of cryovalves at 2 years.1,5,11,12
This study includes patients with known thrombophilia,
infrainguinal outflow obstruction, and sometimes noncom-
pliance with anticoagulation therapy. Since this graft will be
used in patients with these types of disorders, the study
group reflects clinical reality. In these patients, competency
and patency after insertion of cryopreserved vein valve
allografts are much inferior to that after transfer of autolo-
gous vein grafts.
Thrombosis may recur in the allograft as a phenome-
non of the original thrombotic disease because of poor
inflow and as a secondary event to graft rejection. The cause
is probably multifactorial. It is obvious, however, that
Fig 1. Cumulative patency rate of cryovalve segments. Number of limbs at risk at each interval is given, as well as
standard error of the mean ( 9%-13%). Dashed line, SE  10%.
Fig 2. Cumulative rate of competent cryovalve segments. Number of limbs at risk at each interval is given, as well as
standard error of the mean ( 9%-11%). Dashed line, SE  10%.
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mismanagement of anticoagulation therapy contributes to
occlusion of the graft. It is vitally important that anticoag-
ulation therapy be meticulously monitored after cryovalve
insertion and international normalized ratio kept at ade-
quate therapeutic levels. When warfarin sodium is discon-
tinued or anticoagulation is insufficient, the inserted cryo-
valve segment inevitably becomes occluded. This is
contrary to the autologous axillary vein transfer, which has
high patency with low-dose warfarin sodium treatment (1
to 2.5 mg/d with no monitoring), even in patients with
severely scarred, trabeculated postthrombotic veins.3,5
Cryovalve insertion requires more intense anticoagulation
therapy to keep the valve patent than other valve repairs do.
The thrombus appears to involve only the cryovalve seg-
ment, and although a marked inflammatory reaction is
often observed, no further distal extension or pulmonary
embolism has been noted. Occlusion can be expected even
with adequate anticoagulation therapy, but the occlusion
rate is lower.
The high rate of incompetence of cryopreserved venous
valves after thawing is cause for concern. Three fourths of
the cryovalves required a transcommissural valve repair
before insertion. Competency certification by the manufac-
turer is based on testing of the valve with 120 mm Hg of
counterflow pressure immediately before cryopreservation.
Rather than faulty testing, the high percentage of reflux
after thawing indicates that structural changes related to
the cryopreservation and thawing procedures may occur.
Thermal fractures, 50% decrease of smooth muscle and
connective tissue function, and marginal decrease of venous
compliance have been described.13,14 Repaired valves did
not fare any worse than nonrepaired valves.
The cumulative ulcer recurrence-free rate at 3 years was
50% after cryovalve insertion. A higher rate of 73% to 84%
has been observed with autologous vein grafts in groups of
similar patients.1,2,5 As in autologous vein grafts, nonheal-
ing or recurrence of stasis ulcer is rare when the cryovalve is
competent. Thus the higher ulcer recurrence rate appears
to be related to progressive failure of the repair with the
cryopreserved valve. In patients in whom the graft oc-
cluded, symptoms did not always worsen. Three of five
patients with initially healed ulcer had no immediate recur-
rence of ulcer at the time of obstruction, although this may
occur later after recanalization. Total occlusion, at least in
the short term, will abolish reflux and mimic a competent
valve hemodynamically. The improved clinical situation
was not reflected in better hemodynamic test results.
The high morbidity associated with this procedure is of
concern and was thought to be linked to the immunologic
reaction. One cryovalve had to be explanted because of a
violent inflammatory reaction and acute rejection. Another
investigator has also had this experience in one patient
(Robert L. Kistner, personal communication, 2001). The
cryopreserved saphenous allografts are immunogenic and
elicit a response, albeit weak.15,16 It is possible that the high
morbidity is linked to an immunologic response and that
ABO matching is not sufficient in these patients.
Two working theories can be suggested for why cryo-
valves yield results so inferior to those with autologous vein
repair. One theory is based on structural damage due to
cryopreservation and the other on an immunologic re-
sponse. Even though the endothelium of the thawed cryo-
valve looks normal, we do not know whether it actually
survives after insertion.17,18 If there is damage or necrosis
of the endothelium after implantation, the cause may be
preservation-related or secondary to an immunologic reac-
tion. Scanning electron microscopy of the thawed vein
demonstrates apparently viable endothelium.12,18,19 The
Fig 3. Cumulative ulcer recurrence-free rate for 18 ulcerated limbs after cryovalve insertion. Number of limbs at risk
at each interval is given, as well as standard error of the mean ( 7%-14%). Dashed line, SE  10%).
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long-term biologic viability of the endothelium after clini-
cal insertion, however, remains uncertain.
Venous allografts are antigenic.15,16 Cryopreservation
does not seem to substantiallly diminish antigenicity. En-
dothelium is rich in class II antigens, whereas collagen
probably expresses only minor antigens.20 Some patients
may have increased levels of preformed antibodies as a
result of previous blood transfusions or pregnancy. The
antigenic response may be amplified by endothelial injury
from any cause. Mitigation of the immune response may
lead to adaptation and preservation of the allograft matrix
and allow creeping replacement of allograft endothelium
with endothelium of host origin. Attempts at immunologic
modulation with low-dose azathioprine in human beings
has yielded poor results.21 Newer immunosuppressive
agents that act much earlier in the immune cycle, eg,
cyclosporine A, may be more promising than azathio-
prine.22 Early observations on insertion of decellularized
cryovalve implants have also shown substantial decrease in
antigenicity, which appears to enable re-endothelialization
from the host.23
In conclusion, compared with autologous vein transfer,
valve reconstruction with cryopreserved venous valve allo-
grafts is associated with high morbidity, high occlusion
rate, poor cumulative midterm rate of patent grafts with
competent valves, and poor clinical results. The procedure
should not be used as a primary technique for valve recon-
struction, and it is questionable whether it is useful even in
patients in whom autologous reconstruction techniques
have been exhausted. Although patients do not fare worse
in the short term, and sometimes even improve, when an
occlusion occurs ligation of the superficial femoral vein is a
less expensive treatment.24 The basis of the high failure rate
of cryovalves is unclear. It may be immunologic or due to
loss of endothelial cover after implantation. Further im-
provement of cryopreservation technique, immunologic
modifications, and better matching must be explored if
cryovalves are to be a viable alternative in valve repair.
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